NIH-funded research R01 grant

Improving MRI imaging of oxygen levels in various diseases

Official title: Enabling systemic delivery of europium-containing contrast agents for magnetic resonance imaging

Funded at Wayne State University · NIH-10996302 · Data updated 2026-11-12

This study is working on new ways to improve MRI scans by using special agents that help doctors see oxygen levels in the body better, which can help with diagnosing and treating conditions like cancer and kidney problems.

More Magnetic Resonance Imaging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWayne State University
NIH-funded
Lab location1 site (Detroit, United States)
Project startMay 10, 2025
Project endMarch 31, 2029
Funding year2025
Award (this year)$578,863
NIH project number1R01EB035631-01A1
Project IDNIH-10996302 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from conditions related to hypoxia, such as certain cancers, kidney diseases, or neurological disorders.

Less likely to help

Patients with conditions that do not involve hypoxia or those who are not undergoing imaging procedures may not benefit from this research.

What this research studies

This research focuses on developing new contrast agents that can be delivered throughout the body to enhance magnetic resonance imaging (MRI) of oxygen levels, which is crucial for diagnosing and treating diseases like cancer and kidney disorders. The team aims to overcome current limitations in the delivery of europium-based agents by improving their stability and effectiveness in the bloodstream. By creating hypoxia-sensing probes, this research seeks to provide better diagnostic tools for conditions linked to low oxygen levels in tissues.

Why it matters

Potential benefit: If successful, this research could lead to more accurate imaging techniques that help in the early detection and treatment of various diseases associated with hypoxia.

How similar studies have gone: Previous research has shown promise in developing hypoxia-responsive contrast agents, indicating that this approach has potential for success.

Where this research is happening

  • Wayne State University
    Detroit, United States
    Active

Researchers

  • Principal investigator: Allen, Matthew J — Wayne State University
  • Study coordinator: Allen, Matthew J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.